NeuroVive Pharmaceutical AB

NeuroVive Pharmaceutical AB (publ) are pioneers in mitochondrial research and development. Their focus is on producing drug candidates that protect the integrity of the mitochondria, and enhance their function in indications with pressing medical need.

Research and development is conducted both in-house and in collaboration with leading international partners. NeuroVive was founded by research physicians with the ambition of transforming research results into new treatments in therapeutic areas with unmet medical needs, including serious diseases that could lead to organ damage and unusual diseases where current therapy options are extremely limited.